GJ

Gagan Jain

Active Director Director DIN 03601942
DIN 03601942 First appointment Sep 2011 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2011
Shareholding value •••• Premium profile

About Gagan Jain

Data last updated:

Gagan Jain is a Director at Clove Biogenesis Private Limited (since 2011). The company operates in Trading. Clove Biogenesis Private Limited reported revenue of ₹52.4 Lakh (FY 2017).

DIN 03601942
Primary Designation Director
Industry Trading
First Appointment 06 Sep 2011
Oldest Company Age 15 yrs
Largest company Clove Biogenesis Private Limited · ₹52.4 Lakh (FY 2017)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Clove Biogenesis Private Limited U24232DL2011PTC224633
Director06 Sep 20112011₹52.4 Lakh (FY 2017)Active

Board colleagues of Gagan Jain

NameDINCompanyDesignation
Naveen Jain00786679Clove Biogenesis Private LimitedDirector

Directorship timeline

Open interactive timeline →
Clove Biogenesis Private Limited
Premium access

Shareholding and investment profile for Gagan Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gagan Jain

Gagan Jain currently holds 1 directorship: Clove Biogenesis Private Limited (Director, since 06 Sep 2011, revenue ₹52.4 Lakh (FY 2017)).

Gagan Jain was first appointed on 06 Sep 2011 as Director at Clove Biogenesis Private Limited.

The current boards of Gagan Jain's companies include Naveen Jain (Clove Biogenesis Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available